Just when you thought Bristol Myers Squibb had finished its epic game of corporate musical chairs, they've decided to pull out even more...

In what can only be described as a stunning display of pharmaceutical mismanagement, Lexicon Pharmaceuticals has managed to achieve what...

Takeda offered "limited details" on what its "efficiency program" would entail. The company said it would focus on "organizational...

Look, I'm not trying to pick on Pfizer here, but they keep giving me material that's impossible to ignore. And finally, someone with...